Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness
- 1 August 1988
- Vol. 6 (4) , 299-303
- https://doi.org/10.1016/0264-410x(88)90173-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Production and immunological analysis of recombinant hepatitis B vaccineJournal of Infection, 1986
- Vaccines made from recombinant yeast cellsVaccine, 1986
- Antibody responses to recombinant and plasma derived hepatitis B vaccines.BMJ, 1986
- Synthesis in cho cells of hepatitis B surface antigen containing the PRE-S2 region expression productAnnales de l'Institut Pasteur / Virologie, 1985
- Expression of Amplified Hepatitis B Virus Surface Antigen Genes in Chinese Hamster Ovary CellsNature Biotechnology, 1985
- Acceptance of Hepatitis B Vaccine by Hospital PersonnelInfection Control, 1985
- A Multi-Hospital Hepatitis B Vaccine Program: Prevalence of Antibody and Acceptance of Vaccination Among High-Risk Hospital EmployeesInfection Control, 1985
- Who should be immunised against hepatitis B?BMJ, 1984
- Synthesis of hepatitis B surface and core antigens in E. coliNature, 1981
- Viral hepatitis, type B (MS-2 strain). Studies on active immunizationPublished by American Medical Association (AMA) ,1971